UTHealth Neurosciences and McGovern Medical School
McGovern Medical School at UTHealth brings together a team of world-class clinicians, researchers and educators through UTHealth Neurosciences – the largest neuroscience provider in South Texas and one of only a few institutions in the country to provide all aspects of neuroscience care, from neurology to neurosurgery to neurorehabilitation. UTHealth Neurosciences’ infrastructure includes more than 150 nationally recognized faculty members. This allows the extension of its neuroscience expertise and capabilities outside the Texas Medical Center with outpatient clinics located across the Greater Houston area.
UTHealth Neurosciences physicians staff neuroscience units at acute care hospitals across the Memorial Hermann system. McGovern Medical School residents in the Vivian L. Smith Department of Neurosurgery have the opportunity to train at Memorial Hermann-Texas Medical Center, a Level I Trauma Center with an acute and complex case load, as well as at Memorial Hermann Southwest Hospital, which is in pursuit of Level II trauma status.
SCOPE OF SERVICES
- Brain Tumor
- Brain Aneurysm and Hemorrhage
- Critical Care and Neurotrauma
- Face Pain and Headache
- Neuro Oncology
- Pediatric Neurosurgery
- Spine Disorders
HISTORY OF FIRSTS
- The first Stroke Center in Houston and one of the first dedicated stroke programs in the world.
- The first and only stroke program in Texas to meet The Joint Commission’s rigorous standards for the highly coveted Comprehensive Stroke Center certification.
- Launched the first Mobile Stroke Unit in the United States to deliver clot-busting treatment onsite within the first hour of symptom onset.
- The first and only hospital in the south-central United States offering intra-arterial chemotherapy for retinoblastoma, the most modern treatment for the disease.
- Site of the first single-center clinical trial for recurrent medulloblastoma, ependymoma and atypical teratoid-rhabdoid tumors using the direct infusion of chemotherapy into the fourth ventricle.
- The first in Texas to use robotic stereo encephalography (SEEG) for 3-D mapping of epileptic seizures.
- The first in Houston to offer amyloid imaging, a new diagnostic tool that enables physicians to diagnose Alzheimer’s disease and will give researchers insights into how they might one day prevent the disorder.
- The first center to conduct a national, multicenter trial for hypothermia in head injury.
- The first neurosurgery center to offer all advanced modalities of treatment – expert microsurgery, Gamma Knife® radiosurgery and interventional neuroradiology/endovascular surgery – for complex lesions.
- The North American leader in studies of primary progressive multiple sclerosis and the most active center in Texas in the conduct of organized clinical trials of new therapies for MS.
- The first facility in Houston and one of the first in the United States to test the clot-dissolving drug tPA for acute stroke.
- The first center in Houston to test and prove the efficacy of three disparate treatments for stroke prevention: carotid surgery; administration of antiplatelet drugs, including aspirin; and patent foramen ovale closure.
- One of the first centers in the nation to offer MR-guided laser interstitial thermal therapy (MRgLITT) using the Visualase™ system for the treatment of well-delineated focal epilepsies.
- The first facility in the region to do vagus nerve stimulation.
- The first clinical magnetoencephalography (MEG) sensor to Houston and have updated the technology to the Elekta Neuromag® TRIUX.
- One of only a few inpatient Epilepsy Monitoring Units in the country with the unique capability of simultaneously performing electroencephalography and polysomnography.